1 – 123 of 123
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
2024) In Cancer Causes and Control(
- Contribution to journal › Article
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
(
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
(
- Contribution to journal › Article
- 2023
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
(
- Contribution to journal › Article
-
Mark
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2
(
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
- 2022
-
Mark
Research Paper Impact of combining vitamin C with radiation therapy in human breast cancer : Does it matter?
(
- Contribution to journal › Article
-
Mark
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence : A Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
(
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
(
- Contribution to journal › Article
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
(
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article
- 2019
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Patients' and physicians' disagreement on patients' understanding of clinical cancer trial information : A pairwise pilot study of mirroring subjective assessments compared with objective measurements
(
- Contribution to journal › Article
- 2018
-
Mark
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
(
- Contribution to journal › Article
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
(
- Contribution to journal › Article
-
Mark
Patients' reasoning regarding the decision to participate in clinical cancer trials : an interview study
(
- Contribution to journal › Article
-
Mark
Increasing preoperative body size in breast cancer patients between 2002 and 2016 : implications for prognosis
(
- Contribution to journal › Article
-
Mark
Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment
(
- Contribution to journal › Article
-
Mark
Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families
(
- Contribution to journal › Article
- 2017
-
Mark
Högt ER-beta-uttryck starkt skyddande mot återfall hos de kvinnor som fått cytostatika
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Östrogenreceptor-beta kopplad till bättre prognos vid bröstcancer
(
- Contribution to journal › Article
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
(
- Contribution to journal › Article
-
Mark
Smoking impacts endogenous estradiol and testosterone levels in young healthy women
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13 Suppl).(
- Contribution to journal › Published meeting abstract
-
Mark
Body constitution in young healthy women from breast cancer higher risk families in relation to smoking
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13).(
- Contribution to journal › Published meeting abstract
-
Mark
Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
(
- Contribution to journal › Article
- 2016
-
Mark
Rökare med aromatashämmare mot bröstcancer hade sämre prognos
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer
(
- Contribution to journal › Article
-
Mark
CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
(
- Contribution to journal › Article
-
Mark
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
(
- Contribution to journal › Article
-
Mark
Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.
(
- Contribution to journal › Article
-
Mark
Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
-
Mark
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
(
- Contribution to journal › Article
-
Mark
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
(
- Contribution to journal › Article
- 2014
-
Mark
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.
(
- Contribution to journal › Article
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
(
- Contribution to journal › Article
-
Mark
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
37p * androgen receptor expression in a population-based prospective breast cancer cohort.
(
- Contribution to journal › Published meeting abstract
-
Mark
Joint effects of genes, body constitution, and lifestyle: exploring novel pathways to predict prognosis and response to therapy in breast cancer
2014) The ninth International Conference of Anticancer Research, 6–10 October 2014, Sithonia, Greece In Anticancer research 34(10). p.5974-5975(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events.
(
- Contribution to journal › Article
-
Mark
Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.
(
- Contribution to journal › Article
-
Mark
Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
(
- Contribution to journal › Article
-
Mark
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort
(
- Contribution to journal › Article
-
Mark
Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients.
(
- Contribution to journal › Article
-
Mark
Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.
(
- Contribution to journal › Article
- 2011
-
Mark
IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
(
- Contribution to journal › Article
-
Mark
IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer
(
- Contribution to journal › Article
-
Mark
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Emergency cesarean sections can be predicted by markers for stress, worry and sleep disturbances in first-time mothers.
(
- Contribution to journal › Article
-
Mark
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
-
Mark
Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.
(
- Contribution to journal › Article
-
Mark
Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Development of a scoring rubric for A to F grading and assessment of Master’s Theses that are using quantitative methodology
2011)(
- Book/Report › Report
- 2010
-
Mark
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers : implications for risk prediction
(
- Contribution to journal › Article
-
Mark
Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women.
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
(
- Contribution to journal › Article
-
Mark
IGF1 and IGFBP3 Polymorphisms and Plasma Levels in Women
(
- Contribution to journal › Letter
-
Mark
CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.
(
- Contribution to journal › Article
- 2008
-
Mark
Polygenes, risk prediction, and targeted prevention of breast cancer
(
- Contribution to journal › Letter
-
Mark
Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk.
(
- Contribution to journal › Article
-
Mark
Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer.
(
- Contribution to journal › Article
-
Mark
Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status.
(
- Contribution to journal › Article
- 2007
-
Mark
Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women.
(
- Contribution to journal › Article
-
Mark
Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
(
- Contribution to journal › Article
-
Mark
Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
(
- Contribution to journal › Article
-
Mark
CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women
(
- Contribution to journal › Article
- 2006
-
Mark
Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: A pilot study comparing pre- and post-operative levels
(
- Contribution to journal › Article
-
Mark
Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
(
- Contribution to journal › Article
-
Mark
Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
(
- Contribution to journal › Article
-
Mark
Of cup and bra size: Reply to a prospective study of breast size and premenopausal breast cancer incidence.
(
- Contribution to journal › Letter
- 2005
-
Mark
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
(
- Contribution to journal › Article
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
-
Mark
Prevalence of urinary incontinence in relation to self-reported depression, intake of serotonergic antidepressants, and hormone therapy in middle-aged women: a report from the Women's Health in the Lund Area study.
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
(
- Contribution to journal › Article
-
Mark
Naturläkemedel och hormonpreparat potentiell risk för bröstcancerpatienter. Studie kartlägger bruk av medel som kanske motverkar behandlingen
(
- Contribution to journal › Article
- 2004
-
Mark
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
(
- Contribution to journal › Article
- 2003
-
Mark
Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value
(
- Contribution to journal › Article
-
Mark
A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)
(
- Contribution to journal › Article
-
Mark
Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
(
- Contribution to journal › Article
- 2002
-
Mark
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Familial and hormonal risk factors for papillary serous uterine cancer
(
- Contribution to journal › Article
- 2001
-
Mark
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk
(
- Contribution to journal › Article
-
Mark
CYP gene polymorphisms and early menarche
(
- Contribution to journal › Article
-
Mark
Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
(
- Contribution to journal › Letter
-
Mark
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women
(
- Contribution to journal › Article
- 1999
-
Mark
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
(
- Contribution to journal › Article
-
Mark
Reproductive factors in hereditary breast cancer
(
- Contribution to journal › Article
-
Mark
Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study
(
- Contribution to journal › Article
-
Mark
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2
(
- Contribution to journal › Article
- 1998
-
Mark
BRCA1-positive patients are small for gestational age compared with their unaffected relatives
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women
(
- Contribution to journal › Article
-
Mark
Do BRCA1 mutations affect the ability to breast feed? Significantly shorter length of breast feeding among BRCA1 mutation carriers compared with their unaffected relatives.
(
- Contribution to journal › Article
- 1997
-
Mark
Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years
(
- Contribution to journal › Article
-
Mark
Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients
(
- Contribution to journal › Article
- 1996
-
Mark
Effects of Oral Contraceptives on Endogenous Hormones, Body Constitution, and Breast Epithelium in Healthy, Young Women
1996)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors
(
- Contribution to journal › Article
- 1995
-
Mark
Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use
(
- Contribution to journal › Article
- 1994
-
Mark
Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives
(
- Contribution to journal › Article
- 1992
-
Mark
Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits
(
- Contribution to journal › Article